A new framework and set of rules for continuing professional development were approved yesterday by the General Pharmaceutical Council (14 April 2011).
However, council members have called for some longer-term thinking and evidence gathering to establish the cost-effectiveness of the CPD process, both for the regulator and for registrants, and to ensure that it is an effective way of ensuring registrants’ fitness to practice.
"We need evidence that [CPD] is actually linked with outcomes," said council member Keith Wilson, who is head of the school of pharmacy and deputy dean at the school of life and health sciences at Aston University.
To read the full story click here.
Extract taken from PJ Online